Ultragenyx Pharmaceutical Inc. (RARE): Price and Financial Metrics
RARE Price/Volume Stats
| Current price | $26.61 | 52-week high | $60.37 |
| Prev. close | $27.41 | 52-week low | $26.46 |
| Day low | $26.46 | Volume | 1,927,337 |
| Day high | $27.50 | Avg. volume | 1,168,956 |
| 50-day MA | $35.52 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 2.52B |
RARE Stock Price Chart Interactive Chart >
Ultragenyx Pharmaceutical Inc. (RARE) Company Bio
Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company was founded in 2010 and is based in Novato, California.
RARE Price Returns
| 1-mo | -28.76% |
| 3-mo | N/A |
| 6-mo | -33.48% |
| 1-year | -37.80% |
| 3-year | -49.69% |
| 5-year | -69.01% |
| YTD | -36.75% |
| 2024 | -12.02% |
| 2023 | 3.22% |
| 2022 | -44.90% |
| 2021 | -39.25% |
| 2020 | 224.12% |
Continue Researching RARE
Want to do more research on Ultragenyx Pharmaceutical Inc's stock and its price? Try the links below:Ultragenyx Pharmaceutical Inc (RARE) Stock Price | Nasdaq
Ultragenyx Pharmaceutical Inc (RARE) Stock Quote, History and News - Yahoo Finance
Ultragenyx Pharmaceutical Inc (RARE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...